Clinical Trials
9 trialsNCT02312206 2023-11-14
VITAL
Prothena Biosciences Ltd.
Phase 3 Terminated
NCT02994784 2023-05-24
Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
Boston Medical Center
Phase 2 Terminated
NCT00726830 2020-09-24
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase NA Terminated
NCT02603172 2019-09-23
A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis
GlaxoSmithKline
Phase 1 Terminated
NCT02613182 2019-05-16
OLE
Prothena Biosciences Ltd.
Phase 2 Terminated
NCT03154047 2019-03-26
Study in Subjects With Light Chain (AL) Amyloidosis
Prothena Biosciences Ltd.
Phase 2 Terminated
NCT02489500 2018-09-10
VelRand
Boston Medical Center
Phase 3 Terminated
NCT00681044 2017-04-28
HD Melphalan and SCT in Patients With IGDD or LCDD
Boston Medical Center
Phase 2 Terminated
NCT00075608 2017-01-27
2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis
Boston Medical Center
Phase 2 Terminated